Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
Status:
Completed
Trial end date:
2016-08-26
Target enrollment:
Participant gender:
Summary
The proposed study is designed to evaluate (i) the effects of saxagliptin, with or without
acarbose, on gastric emptying, postprandial glycaemia, and plasma intact GLP-1, insulin,
C-peptide and glucagon after a high carbohydrate meal, and (ii) whether the magnitude of the
effects of saxagliptin and/or acarbose is related to the rate of gastric emptying, in
patients with type 2 diabetes.